Jane Street’s Aratana Therapeutics, Inc. PETX Stock Holding History

Jane Street’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-11,827	Closed	-$61K	–	6175
2019 Q2	$61K	Buy	+11,827	New	+$53.2K	﹤0.01%	4932
2018 Q2	–	Sell	-81,952	Closed	-$361K	–	5956
2018 Q1	$361K	Buy	81,952 +71,486	+683%	+$319K	﹤0.01%	3826
2017 Q4	$55K	Buy	+10,466	New	+$64K	﹤0.01%	4419
2014 Q4	–	Sell	-11,012	Closed	-$111K	–	3272
2014 Q3	$111K	Sell	11,012 -7,303	-40%	-$88.5K	﹤0.01%	2347
2014 Q2	$286K	Buy	+18,315	New	+$260K	﹤0.01%	1881

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Jane Street's PETX Position: Q3 2019 in Review

Jane Street sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 11,827 shares — an estimated $61K sold.

Jane Street first reported a position in PETX in Q2 2014 and held it in 5 quarters. The position peaked at $361K in Q1 2018. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Jane Street reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Jane Street sold 11,827 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $61K.
Jane Street first reported a position in Aratana Therapeutics, Inc. in Q2 2014 and held it in 5 quarters.
Jane Street's Aratana Therapeutics, Inc. position peaked at $361K in Q1 2018.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Jane Street's 13F filing for Q3 2019, filed 14 Nov 2019.